Toward pre-treatment prediction of biologic DMARD response in RA

被引:1
|
作者
Phillips, Robert
机构
[1] Nature Reviews Rheumatology,
关键词
D O I
10.1038/s41584-022-00800-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Results from the R4RA clinical trial indicate that gene signatures in pre-treatment biopsy-derived synovial tissue can predict the response to biologic DMARDs in patients with rheumatoid arthritis.
引用
收藏
页码:365 / 365
页数:1
相关论文
共 50 条
  • [1] Toward pre-treatment prediction of biologic DMARD response in RA
    Robert Phillips
    [J]. Nature Reviews Rheumatology, 2022, 18 : 365 - 365
  • [2] THE PRE-TREATMENT SWOLLEN JOINT COUNT IS BEST PREDICTOR FOR RESPONSE TO BIOLOGIC THERAPY IN RA
    Estrach, C.
    Mpofu, S.
    Thompson, R. N.
    Williams, E.
    Abernethy, V. E.
    Moots, R. J.
    [J]. RHEUMATOLOGY, 2003, 42 : 87 - 87
  • [3] Factors Influencing Treatment Adjustments in RA Patients - Biologic DMARD Treatment Start and Options
    Taylor, Peter C.
    Sullivan, Emma
    Wood, Robert
    Piercy, James
    Alten, Rieke
    Gomez-Reino, Juan J.
    Bertin, Philippe
    Caporali, Roberto
    Vasilescu, Radu
    Spurden, Dean
    Alvir, Jose
    [J]. ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [4] Clinical applications of pharmacogenetics: Pre-treatment prediction of antipsychotic response
    Arranz, MJ
    Clark, D
    Mancama, DT
    Parsons, M
    Staddon, S
    Beperet, M
    Arrondo, J
    Mata, I
    Kerwin, RW
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 77 - 77
  • [5] Lower than Expected Levels of DMARD Acquisition Immediately Pre and Post Biologic Initiation in RA Patients
    Choquette, Denis
    Thomas, Oliver
    Arundine, Mark
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 964 - 965
  • [7] SYSTEMATIC REVIEW: COMPARATIVE EFFECTIVENESS OF BIOLOGIC DMARD THERAPIES VERSUS TRADITIONAL DMARD THERAPIES IN RA
    Campbell, Richard C.
    Kingsley, Gabrielle
    Scott, David
    [J]. RHEUMATOLOGY, 2009, 48 : I63 - I63
  • [8] Pre-treatment haemoglobin levels and the prediction of response to neoadjuvant chemotherapy in breast cancer
    Beresford, M. J.
    Burcombe, R.
    Ah-See, M. L.
    Stott, D.
    Makris, A.
    [J]. CLINICAL ONCOLOGY, 2006, 18 (06) : 453 - 458
  • [9] Low Probability of Clinical Worsening Following Switching Biologic DMARD in Patients with RA and Partial Response to Adalimumab
    Curtis, Jeffrey
    Aletaha, Daniel
    Burmester, Gerd
    Ford, Kerri
    van Hoogstraten, Hubert
    Leher, Henry
    Thangavelu, Karthinathan
    Bykerk, Vivian
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] Efficacy and Safety of Tofacitinib Following Inadequate Response to Nonbiologic DMARD or Biologic DMARD
    Charles-Schoeman, C.
    Burmester, Gerd
    Nash, P.
    Zerbini, C. A. F.
    Anway, S.
    Kwok, K.
    Hendrikx, T.
    Bananis, E.
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S212 - S213